News brief­ing: Bio­gen gets a quick date with an FDA pan­el for con­tro­ver­sial ad­u­canum­ab; Abeona CEO, board mem­bers ex­it — shares im­plode

Mark your cal­en­dars for No­vem­ber 6, which looms as the next ma­jor test for Bio­gen’s ad­u­canum­ab. That’s the day the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.